Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 8, Number 8—August 2002


DNA Vaccine Expressing Conserved Influenza Virus Proteins Protective Against H5N1 Challenge Infection in Mice

Suzanne L. Epstein*Comments to Author , Terrence M. Tumpey†, Julia A. Misplon*, Chia-Yun Lo*, Lynn A. Cooper‡, Kanta Subbarao‡, Mary Renshaw‡, Suryaprakash Sambhara‡, and Jacqueline M. Katz‡
Author affiliations: *Food and Drug Administration Rockville, Maryland, USA; †United States Department of Agriculture, Athens, Georgia, USA; ‡Centers for Disease Control and Prevention, Atlanta, Georgia, USA;

Main Article


Effect of DNA vaccination on replication of HK/486 challenge virus in mouse lungsa

Immunization No. mice Lung titer +/- SE
Expt 1A
A/NP+A/M DNA 6 5.7 ± 0.33
B/NP + blank DNA 6 6.9 ± 0.18b
None 6 6.9 ± 0.22c
Expt 1B
Live X-31 virus 4 3.6 ± 0.36d
None 4 7.1 ± 0.1

aMice were immunized intramuscularly with 100 μg each of influenza A nucleoprotein and matrix DNA (A/NP+A/M DNA) or controls with 100 μg each of influenza B nucleoprotein DNA (B/NP)+blank DNA (total dose 200 μg/mouse on each occasion), three times at 2-week intervals. Two weeks after the last dose of DNA, mice were challenged with 100 mouse infectious dose (MID)50 of HK/486 intranasally. X31 virus-primed mice and their controls were challenged along with DNA-vaccinated mice. On day 6 after challenge, mice were sacrificed and lungs collected for titration of virus infectivity.
bDiffers significantly from A/NP+A/M group by analysis of variation (ANOVA), p=0.0082.
cDiffers significantly from A/NP+A/M group by ANOVA, p=0.011.
dDiffers significantly from unimmunized group by ANOVA, p<0.001.

Main Article